Although several studies have reported on the relation between high blood pressure (BP) and impaired activities of daily living (ADL), only a few studies have reported on the relation of high BP in middle-aged subjects with future impaired ADL. Furthermore, no studies reported an excess impaired ADL due to non-normal BP. Using ADL 1999 data, we compared data from NIPPON DATA80 survivors without impaired ADL (N ¼ 1816) with those with impaired ADL (N ¼ 75) using baseline BP information collected in 1980. We analysed participants who were aged 47-59 years at baseline. Multiple adjusted logistic regression analyses were used to estimate the risk of impaired ADL, according to baseline BP categories using Joint National Committee 7 guidelines (normal BP, prehypertension, stage 1 hypertension (HT) and stage 2 HT). Subjects who used antihypertensive medications were classified as having stage 2 HT. We calculated excess impaired ADL due to non-normal BP. Compared with normal BP categories, the adjusted odds ratio (OR) and 95% confidence interval (CI) of having impaired ADL was higher in subjects with prehypertension (OR ¼ 1.50, 95% CI: 0.55-4.09), stage 1 HT (OR ¼ 1.56, 95% CI: 0.56-4.32) and stage 2 HT (OR ¼ 2.96, 95% CI: 1.09-8.05). Non-normal BP explained 45% (33.7/75) of impaired ADL. A positive relation of BP categories with the composite end point of mortality and impaired ADL was also observed. In conclusion, controlling BP in middle age may prevent deaths and future ADL decline.
Introduction
Hypertension (HT) is one of the strongest risk factors for cardiovascular disease mortality and all-cause mortality. [1] [2] [3] Thus, control of blood pressure (BP) can increase lifespan. As the proportion of elderly people increases, the importance of preventing physical dysfunction, that is, impaired ability to perform activities of daily living (ADL), becomes a major public health concern for older people. 4 We previously reported that the main cause of impaired ADL in Japan was stroke. 4 Other studies have shown that participants who died from stroke had a longer period of disability before death compared with participants who died of other causes. 5 It is well known that HT is a strong risk factor for stroke. [1] [2] [3] Therefore, HT may also be strongly associated with impaired ADL. However, only a few studies have reported the relation of HT with physical dysfunction or impaired ADL. [6] [7] [8] [9] [10] [11] [12] Furthermore, these studies primarily included elderly participants. [6] [7] [8] [9] Only a few studies have examined the relation of BP measured at middle age and future disability, 11, 12 and no studies have reported on the contribution of BP to impaired ADL. Furthermore, if we combined impaired ADL and deaths together, we can calculate the relation of BP with being alive without impaired ADL.
The objective of this study was to investigate the relation between the ability to perform ADL in 1999 and baseline BP measured in 1980 among a general population of Japanese subjects aged 47-59 years taken from NIPPON DATA80. NIPPON DATA80 is a cohort study that consisted of a representative Japanese sample surveyed in 1980.
Methods

Participants and follow-up
Two cohort studies of the National Survey on Circulatory Disorders comprise the National Integrated Project for Prospective Observation of Noncommunicable Disease and Its Trends in the Aged (NIPPON DATA). Baseline surveys were performed in 1980 (NIPPON DATA80) [13] [14] [15] [16] [17] [18] and in 1990. [19] [20] [21] Detailed methods of NIPPON DATA have been described previously. 13, 17, 19 We analysed the 19-year follow-up data from NIPPON DATA80 in this study.
Baseline surveys were carried out at local public health centres, and all participants had to be capable of reaching the examination centre without assistance.
Biochemical and physical examinations
Baseline BP was measured by trained observers using a standard mercury sphygmomanometer on the right arm of seated participants after at least 5 min of rest. We defined BP categories as follows: stage 2 HT, systolic BP X160 mm Hg and/or diastolic BP X100 mm Hg; stage 1 HT, systolic BP 140-159 mm Hg and/or diastolic BP 90-99 mm Hg; prehypertension, systolic BP 120-139 mm Hg and/or diastolic BP 80-89 mm Hg; normal BP, systolic BP o120 mm Hg and diastolic BP o80 mm Hg. If participants were taking antihypertensive medication, they were categorized into stage 2 HT irrespective of their BP level. Body mass index (BMI) was calculated as weight (kg) divided by height squared (m 2 ). Public health nurses obtained data including smoking habits, as well as current health status and medical history. Non-fasting blood samples were separated by centrifugation within 60 min of collection in 1980 and stored at -70 1C. Blood glucose levels were measured using the cupric-neocuproine method, and the values were adjusted by using the formula ((0.047 Â (glucose concentration in mg per 100 ml))À0.541) to obtain the approximate value measured by the hexokinase method, which gives levels in mmol l À1 . 18 Diabetes was defined as casual blood glucose level of 11.1 mmol l À1 or self-reported diabetes. 18 Serum albumin and total cholesterol levels were measured by a sequential autoanalyzer (SMA12/60; Technicon, Tarrytown, NY, USA) using bromocresol-green staining for albumin and the Lieberman-Burchard direct method for total cholesterol at a specific laboratory (presently the Osaka Medical Center for Health Science and Promotion).
ADL survey
The NIPPON DATA studies performed follow-up ADL surveys in 1994 4 and 1999. In this study, we analysed 1999 data because we wanted to examine the effect of high BP in middle-aged subjects on future ADL decline. The 1999 ADL survey was done in subjects aged X65 years at that time. Participants aged 45 years and younger were not surveyed and some of the participants aged 46 years were not surveyed. Furthermore, because we wanted to study the effect of high BP in middle-aged subjects, we limited the upper age of subjects in this study to those younger than 60 years at baseline.
We asked 300 Public Health Centers to participate in the 1999 ADL survey, and 249 of them agreed. In these areas, 2724 participants were between the ages of 47 and 59 years at baseline. Among them, 75 participants were excluded because of a history of cardiovascular disease (that is, acute myocardial infarction (AMI) or stroke), and because of lack of information on serum total cholesterol levels, blood glucose levels, height, weight and serum albumin levels. The remaining 2649 participants were surveyed; however, 385 died and 84 moved before the ADL survey. Thus, 2180 participants were asked to respond to the ADL survey and 1891 did so (87%) (Figure 1 ). No significant differences were seen between responders and non-responders for baseline age, BP values, use of antihypertensive medications, BMI, smoking status and albumin levels ( Table 1) . Non-responders had a significantly higher total cholesterol level than responders (Po0.01). Blood pressure and future ADL decline A Hozawa et al
Participants were asked about five basic ADL items (feeding, dressing, bathing, toileting and transfer (walking indoors)), as modified from Katz et al. 22 and whether each of these items could be accomplished without help, with partial help or with full help. Participants were also asked whether they had a history of stroke, lower limb fracture and AMI. 4 This survey was conducted through telephone interviews (10.5%), face-to-face interviews at home (80.0%) and other methods (9.5%). Impaired ADLs were defined as partial or full support needed to perform any of the five basic ADL items. As previously reported, 13 ,17,19 we identified participants who had died by computer matching data from Japanese National Vital Statistics records, using area, gender, birth date and death as key codes. We obtained permission to use the National Vital Statistics records from the Management and Coordination Agency of the Government of Japan. The Institutional Review Board of Shiga University of Medical Science (no. [12] [13] [14] [15] [16] [17] [18] 2000) approved the study.
Statistical analysis
Analysis of variance for continuous variables or w 2 -test for proportions were used to compare baseline characteristics. The relationship between BP categories and impaired ADL was calculated using multiple adjusted logistic regression models. The multivariable-adjusted odds ratio (OR) for impaired ADL was adjusted for age, sex, BMI (o18.5, 18.5-24.9, X25 kg m À2 ), cigarette smoking (current, ex-smoker, never smoked), drinking (everyday, sometimes, ex-drinker, never), diabetes, total cholesterol levels and albumin levels. We also added a history of stroke and AMI at the ADL survey as covariates in an additional model to determine the role of stroke or AMI on the relation between high BP and impaired ADL. The normal BP group was used as the reference group. The OR for having impaired ADL was calculated using multiple logistic regression analysis. To identify the effect of BP on being alive without impaired ADL, we also analysed the OR for the composite outcome of impaired ADL and death before the ADL survey (N ¼ 385) using multiple logistic regression analysis. Trend tests were performed by allocating scores 1, 2, 3 and 4 to all participants with normal BP, prehypertension, stage 1 HT and stage 2 HT, respectively.
The percentage of excess impaired ADL due to non-normal BP was calculated as follows: P Â (OR À1)/OR, where P ¼ proportion of cases exposed to the risk factor. 23 All probability values were twotailed and all confidence interval (CIs) were estimated at the 95% level. SAS software (version 9.1, SAS Institute, Cary, NC, USA) was used for analyses. Table 2 shows the baseline characteristics of the 1891 study participants. According to the BP categories, participants in the higher BP categories were older, and had a higher BMI, albumin level, and total cholesterol level than those in the lower BP categories. The proportion of women was higher in the lower BP categories. Table 3 shows the relation of baseline BP categories to impaired ADL. The age-and sexadjusted OR of having impaired ADL was higher in the higher BP categories. The age-and sexadjusted OR (CIs) of prehypertension, stage 1 HT and stage 2 HT were 1.38 (0.51-3.71), 1.49 (0.55-4.06) and 2.92 (1.11-7.67), respectively. This trend was unchanged when we adjusted for BMI, smoking status, drinking status, diabetes, total cholesterol levels and albumin levels. No sex differences were observed for the relation of BP categories and impaired ADL (P for interaction ¼ 0.38).
Results
When we further adjusted for the history of stroke at the end of follow-up, the relation between high BP and impaired ADL was largely attenuated. The adjusted ORs for prehypertension, stage 1 HT and stage 2 HT were 1.59 (0.56-4.53), 1.75 (0.60-5.12) and 2.10 (0.73-6.05), respectively. This suggests that stroke plays an important causal role in the relation between high BP and impaired ADL. On the other To assess the relation between BP and being alive without impaired ADL, we calculated the risk of baseline BP categories using the composite end point of impaired ADL and all-cause death. Of 385 participants who died before the ADL survey, 191 (50%), 46 (12%), 50 (13%), 7 (2%) and 91 (24%) died of cancer, stroke, heart disease, other cardiovascular disease and other causes, respectively. The ORs of the composite end points were 1.22 (0.83-1.78), 1.13 (0.76-1.69) and 1.78 (1.20-2.66) for prehypertension, stage 1 HT and stage 2 HT, respectively (Table 4) .
Discussion
This study revealed a positive correlation between high BP at middle age and impaired ADL in the future, as well as the composite end point of impaired ADL and death. We found that 45% of impaired ADL could be explained by non-normal BP in Japanese subjects. This suggests that, among Japanese subjects, non-normal BP in middle age is an important determinant of future impaired ADL.
There are several prospective studies reporting the relation of BP to physical performance. [6] [7] [8] [9] [10] [11] [12] However, most of these studies investigated elderly populations. [6] [7] [8] [9] Studies focusing on the relation between BP measured at middle age and future ), and smoking (current, ex-smoker), drinking (daily, occasional, ex-drinker), diabetes, total cholesterol and albumin. investigated 2021 participants whose baseline age range was 28-62 years and found long-term HT related to disability, they used 'ever hypertensive,' that is, whether participants were diagnosed with HT during follow-up, as a risk factor. Thus, their study could not conclude whether BP measured at middle age could predict future disability. Reed et al. 11 investigated physical function among 3263 subjects with Japanese ancestry who had information from 28 years before the survey. The baseline age of these participants ranged from 45 to 68 years. They found that the most consistent predictor of healthy aging was low BP. Guralnik et al.
12 also studied participants of the Alameda County Study who were aged 46-70 years at baseline and investigated the relation of high BP with physical function after 19 years. 12 They found that high BP predicted future lower levels of physical function. These latter two findings were mostly consistent with our results showing that high BP at ages 47-59 predicts impaired ADL after 19 years.
It is well known that high BP is associated with a higher risk of stroke. [1] [2] [3] We previously reported the prevalence of impaired ADL and the magnitude of the association with stroke. 4 Similarly, another study in Japan showed that the duration of disability before death was longer in participants who died of stroke than in participants who died of other reasons. 5 In that study, 45% of patients who died from stroke had more than 6 months of disability. 5 These findings are consistent with our results, that is, BP was strongly related with impaired ADL. Our results that adjustment for stroke history at the end of the follow-up largely attenuated the relation between high BP and impaired ADL also support the idea that stroke plays an important role in the relation between high BP and impaired ADL. Although Ohmori et al. 5 also showed that the risk of long-term disability was lower in participants who died from ischaemic heart diseases, which is strongly affected by BP, than in those who died from other causes, our study showed that, overall, higher BP levels at middle age were strongly associated with a future decline in ADL.
We found that 45% of impaired ADL was explained by non-normal BP in our study. This suggests that preventing progression of non-normal BP might yield a lower incidence of ADL decline. Because participants of NIPPON DATA80 included a representative Japanese general population, and the response rate of the ADL survey was high, we believe that these rates are applicable to a general Japanese population. However, this rate may not be applicable to other populations where mortality or incidence rates of stroke are lower. Further studies conducted in other countries that assess the impact of BP on impaired ADL would be of interest.
We also found that high BP was strongly associated with the composite end point of death and impaired ADL. This supports the idea that preventing high BP is important not only for preventing impaired ADL but also preventing death; that is, controlling or managing BP in middle-aged subjects may have the potential to prolong the duration of lives without impaired ADL, thus increasing so called healthy life expectancies. 24 There are several limitations to this study. First, we did not assess baseline ADL conditions. Thus, we could not determine whether participants had been independent at baseline. However, because participants arrived at the baseline exam on foot and because we also excluded participants who had a history of stroke, we considered the effect of the lack of information on baseline ADL on our results to be negligible. Second, we assessed ADL only in 1999, and, some participants progressed to impaired ADL before the ADL survey. However, many participants with impaired ADL died before the ADL survey. Thus, we believe we adequately addressed this limitation by exploring the composite end point of death and impaired ADL. Finally, because we focused on the relation between BP at middle age (o60 years) and future ADL decline, the oldest participants in 1999 were younger than 80 years. In Japan, in 1980, life expectancy at 40 years was 35.5 years for men and 40.2 years for women. 25 Thus, our participants might be too young to assess the impact of BP at middle age on lifetime disability. However, we believe that our information is important to assess the impact of high BP on premature impaired ADL and death.
In conclusion, non-normal BP in middle age is a strong predictor of impaired ADL 19 years later. Nearly half of the impaired ADL in 1999 was shown to be related to non-normal BP in 1980. Non-normal BP also predicted the composite outcome of death and impaired ADL; that is, lower BP in middle age can yield longer healthy life expectancies.
